The Valley Desk

ArticleScience translational medicinePublished

Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Science translational medicine
Published
Subject terms
Cell Line, Tumor; Stromal Cells; Animals; Humans; Mice; Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms; ras Proteins; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Immunotherapy; Drug Resistance, Neoplasm
PubMed ID
39441902
PubMed Central ID
PMC12376167
Added to directory
Source checked

Report a correction or request removal